Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- A biblical “clinical trial”
- 19th century ethical qualms
- Randomized controlled trial (RCT): Streptomycin
- Overview
- Historical factors
- Medical research developments: 19th century
- Medical research developments: 20th century
- Streptomycin
- The professionalization of biostatistics
- Biostatistics: an expanding field of research
- Medical research council and clinical trials
- Bradford Hill’s streptomycin trial
- Bradford Hill’s assessment of the trial
- Response to unethical research on humans
- United States: unethical research practices
- Tuskegee syphilis study
- Bioethics: response to unethical research
- Overarching ethical issues
- Philosophical frameworks
- Utilitarianism
- Immanuel Kant and the ethics of duty
- Kant and the categorical imperative
- Withholding a potentially useful therapy
- Letting chance determine patient assignment
- Avoiding using humans as means to an end
- Relationship of utilitarianism and Kant in RCTs
- An ethical framework for biomedical research
- Conclusions
- Appendix (1)
- Appendix (2)
Topics Covered
- Historical antecedents to the clinical trial
- Pharmacology & mathematical statistics as key for clinical trials
- Shortage of streptomycin during WWII & use of control groups
- Unethical research studies & informed consent by study subjects
- Withholding a potentially useful therapy
- Letting chance determine patient assignment
- Advancing scientific knowledge without reducing study participants to a means to an end
- General ethical frameworks of Utilitarianism & Kantianism
- Eight factors to be considered in designing ethical and scientific studies
Links
Series:
Categories:
Talk Citation
Matthews, J.R. (2018, October 31). Historical and ethical issues in trial design [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 13, 2024, from https://doi.org/10.69645/DXXP4809.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. J. Rosser Matthews has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
One of the most visible forms of
contemporary scientific research is the randomized controlled clinical trial.
In its basic structure,
the clinical trial is a form of experimentation
on human subjects that involves administering
a potentially useful experimental therapy or
intervention to some of the subjects in the trial,
while withholding the therapy or intervention from other subjects in the trial.
The latter is usually referred to as the control group.
Subjects are recruited to the study based on predetermined selection criteria.
And after recruitment, the subjects are randomly
assigned to either the experimental or the control group.
Often, the study participants,
and sometimes those carrying out the trial,
are blinded, meaning that they do not know
which subjects are assigned to which group while the study is going on.
Today, this research methodology is often cited
as the goal standard of scientifically rigorous research.
However, because human subjects are involved,
ethical concerns are always present.
By using concrete historical examples,
this lecture will show how these concerns have been dealt with in the past and explain
the underlying ethical principles that should guide
researchers who design clinical trials in the future.
1:36
In its most elemental aspect,
the clinical trial is predicated on being able to observe
a differential response between groups of
participants when these groups are exposed to different interventions.
One ancient example of this procedure comes from the book of Daniel in the Bible.
When the Babylonian king, Nebuchadnezzar,
conquered Israel, several Jewish children,
including Daniel were taken to the king's palace to be fed rich royal food and wine.
But Daniel refused to eat the royal food and suggested the following experiment.
"Test your servants for 10 days.
Let us be given vegetables to eat and water to drink.
Then let our appearance and the appearance of
the youths who eat the king's food be observed by you."
At the end of 10 days,
it was seen that they were better in appearance and fatter in
flesh than all the youths who ate the king's rich food.
So, the steward took away their rich food and
the wine they were given to drink and gave them vegetables.
Multiple similar examples could be found throughout all of recorded history,
which means that in a sense,
the clinical trial is potentially as old as humanity itself.